Home » Topics » Regulatory » Patents

Patents
RSS

Beijing Scitech-Mq Pharmaceuticals identifies new FGFR4 inhibitors

July 27, 2021

Japan Tobacco divulges new NLRP3 inflammasome inhibitors

July 27, 2021

New glucagon-like peptide 1 derivatives identified at Gan & Lee Pharmaceuticals

July 26, 2021

Multiple kinase inhibitors identified at Medshine Discovery

July 26, 2021

Sunshine Lake Pharma, Dongguan Hec New Drug Research and Development patent RORgammaT antagonists

July 26, 2021

BioWorld MedTech Patent Highlights: Week 28

From Current Patent Gazette

July 23, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Blue Oak Pharmaceuticals describes new antidepressants

July 23, 2021

Memorial Sloan Kettering Cancer Center presents new ULK1 inhibitors

July 23, 2021

Wuhan LL Science and Technology Development divulges P2X4 receptor antagonists

July 23, 2021

Chinese researchers patent coagulation factor XIa inhibitors

July 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...